Moleculin Biotech (MBRX) Q1 2024 Annual Earnings
MBRX·Reported May 10, 2024·After market close
Diluted EPS came in at $-50.50, beat the $-89.75 consensus by $39.25.
Diluted EPS
$-50.50beat by $39.25
Consensus: $-89.75
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Moleculin Biotech's Q1 2024 earnings report.
Moleculin Biotech (MBRX) reported Q1 2024 earnings on May 10, 2024 after market close.
Moleculin Biotech reported diluted EPS of $-50.50 for Q1 2024.
EPS beat the consensus estimate of $-89.75 by $39.25.
You can read the 10-K/A periodic report (0001437749-24-013444) directly on SEC EDGAR. The filing index links above go to sec.gov.